In vivo effect of Pfn1 overexpression on mammary tumour cells has been examined for only one cell line (CAL51) so far where suppression of tumorigenicity was observed (Janke et al, 2000; Wittenmayer et al, 2004). This evidence concerns the gene PFN1 and breast cancer.